Skip to main content

Table 1 Distribution of patients by country (ITT population)

From: Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART)

Country

Ovaleap® (n = 153)

Gonal-f® (n = 146)

Total (N = 299)

Belgium + Germanya

35

30

65

Czech Republic

30

28

58

Hungary

39

38

77

Poland

49

50

99

  1. a3 patients were randomized in Belgium: 1 to Gonal-f® and 2 to Ovaleap®